Business

The Canadian Business Journal, where Juva Life publishes a journal app that provides cannabis patients with personal health and wellness tracking.

Vancouver, British Columbia, March 2, 2022 (GLOBE NEWSWIRE) — Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRANKFURT: 4VV) (“Juva Life”, “Juva” or “Company”), Life sciences companies engaged in pharmaceutical research and development and consumer business in Vancouver production and distribution track consumption by cannabis users and patients and gain insights into how cannabis products affect health. We announced today the launch of a company journal app designed to help you with Wellness.

Doug Crowpek, CEO and Founder of Juba, said: “One of Juva’s main goals is to expand the industry’s knowledge of cannabis efficacy from a scientific point of view. The Journal App provides customers with a personal tracking solution and collects through the research registry. Provides Juva information that complements the data you have created. “

Through the Journal App, cannabis consumers and anyone using hemp-based cannabidiol (CBD) products can track their symptoms, drug use, and results. Consumers can track a variety of health illnesses while documenting the products they consume, their effects on specific symptoms, and the side effects they may experience.

“Data is important in all industries. Through both the Journal App and the WIRB-approved registry, one of the largest repositories of real-world data on the medical effects of cannabis use, including consumer behavior and perceived efficacy. We continue to work on user privacy, but the data we collect is beneficial from a regulatory and scientific point of view and brings great value to Juva’s intellectual property portfolio. ” He added. “All user information related to the Journal App and WIRB Approved Registry is protected by the world’s strictest patient privacy laws, so participants can rest assured that their entries are 100% confidential. All data will be anonymized for the privacy of the patient. “

If you are interested in downloading the journal app, you can download it here. https://shopjuva.com/journalapp/

We also carry out WIRB-approved multi-year research through the Cannabis Research Registration. Upon completion, Juva will have one of the largest datasets of this type and will be able to leverage the data in both dietary supplements, drug development, and clinical programs. This real-world observational data, monitored by physicians and clinicians, is presented to various regulators to show the potential therapeutic benefits of cannabis and hemp-derived compounds.

Juva Life also has a pharmaceutical research and life sciences department that aims to identify the mechanism of action behind the anecdotal ability of cannabis to regulate inflammation. We recently identified the non-cannabinoid compounds JUVA-019 and JUVA-041, applied for a patent, and conducted preclinical studies. This compound has been shown to be effective as a stand-alone compound that suppresses inflammation by regulating certain biomarkers in the body. .. JUVA-019 and JUVA-041, which we have designated as candidates for further preclinical studies, are currently in the process of phenotypic models of age-related chronic diseases.

On behalf of the board

-Doug Chloupek-

Doug Chloupek, CEO and Founder

Juba Life Co., Ltd.

inquiries@juvalife.com

About Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) (FRA: 4VV)

Juva Life employs cutting-edge science to discover, develop and commercialize safe and effective wellness and medicines in both the cannabis consumer segment and the non-cannabinoid-based healthcare industry. The company has successfully followed the 2018 roadmap, starting with standardization of cultivation, extraction and formulation to provide consumers with reproducible benefits. Juva is built on the chemistry skills of these natural product processes and now includes discovery pharmacology. We leverage the revenue generated from our retail business to leverage the Juva-019 and Juva-041 consumer and clinical development efforts, as well as other potentially valuable consumer and pharmaceutical applications. Promotes non-cannabinoid bioactive substances. Juva is working to bring the cannabis market to the next generation investment grade business model in this sector. See below for more information. https://juvalife.com/..

For more information, please contact:

Juba Life Investor Relations

Tel: Tel: +1 833-333-5882 (JUVA)

Email: inquiries@juvalife.com

Description of future prospects

This news release contains statements and information that may constitute “forward-looking information” in the sense of applicable securities law, unless it is a historical fact. Forward-looking information may include statements about financial and other forecasts, as well as future plans, objectives, or financial performance, or the assumptions underlying any of the above. In some cases, forward-looking statements may be “may,” “do,” “can,” “do,” “probably,” “exception,” “anticipate,” “believe,” and “. It can be identified by terms such as “intended”. , “Plan”, “Forecast”, “Project”, “Estimate”, “Forecast”, or their negative expressions, or other similar expressions for matters that are not historical facts. Examples of such statements include, but are not limited to, statements regarding our objectives and business plans. Product development, commercialization strategies and future collaboration.

Forward-looking information includes known and unknown risks, uncertainties, and future results, performance, or performance that express or imply our actual results, performance, or performance by the information about the future. Includes other factors that may differ significantly from. Risks associated with our future business plans. The risk that we will not be able to retain key personnel. Described in the discussions and analysis of our management for the fiscal year ended December 31, 2020 under the heading “Risks and Uncertainties”, as well as the risks that we may not be able to secure on reasonable terms or at all. All other risks that have been. Therefore, readers should not place excessive reliance on such forward-looking information. In addition, forward-looking information is provided only as of the date on which such statements were made. New factors emerge from time to time, and our management anticipates all of such factors and proactively assesses the impact of each such factor on our business, or any factor, or a combination of factors. That is impossible. , Actual results may differ materially from those contained in the forward-looking information. Unless required by law, including securities law, we provide forward-looking information to reflect information or events after the date it was created, or to reflect the occurrence of an unexpected event. We do not undertake any obligation to renew.

CSE is not responsible for the validity or accuracy of this release.


CBJ News Maker

The Canadian Business Journal, where Juva Life publishes a journal app that provides cannabis patients with personal health and wellness tracking.

Source link The Canadian Business Journal, where Juva Life publishes a journal app that provides cannabis patients with personal health and wellness tracking.

Related Articles

Back to top button